
Anglonordic Life Science Conference
March 8, 2021/by Beth Zalcman
Sachs Neuroscience Innovation Forum
March 8, 2021/by Beth Zalcman
How did pharma firms develop COVID-19 vaccine so quickly?
February 18, 2021/by Beth Zalcman
How will the new administration affect non-dilutive funding?
February 7, 2021/by Beth Zalcman
How COVID-19 raised the profile of non-dilutive funding
February 7, 2021/by Beth Zalcman
Inova Immunology Virtual Partnering
January 26, 2021/by Beth Zalcman
Inova Oncology Virtual Partnering
January 26, 2021/by Beth Zalcman
Opening Remarks at NDFS
January 21, 2021/by Beth Zalcman
BARDA at NDFS
January 21, 2021/by Beth Zalcman
NIDDK at NDFS
January 21, 2021/by Beth Zalcman
NIA at NDFS
January 21, 2021/by Beth Zalcman
NHLBI at NDFS
January 21, 2021/by Beth ZalcmanSearch
Recent Posts
- LSX Investival Showcase, November 17, 2025, LondonSeptember 11, 2025 - 10:04 am
- BioEurope, November 3-5, 2025, ViennaSeptember 9, 2025 - 10:04 am
- BioFuture, October 13-15, 2025, New YorkSeptember 4, 2025 - 11:36 am
- Sachs Associates Biotech in Europe Forum, October 8-9, 2025, BaselSeptember 2, 2025 - 12:47 pm
- Sachs Associates HealthTech Investment Forum, October 7, 2025, BaselSeptember 2, 2025 - 12:47 pm